SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-206678"
 

Search: onr:"swepub:oai:DiVA.org:uu-206678" > Improving the Diagn...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Improving the Diagnosis and Management of Neuroendocrine Tumors : Utilizing New Advances in Biomarker and Molecular Imaging Science

Giandomenico, Valeria (author)
Uppsala universitet,Onkologisk endokrinologi
Modlin, Irvin M. (author)
Pontén, Fredrik (author)
Uppsala universitet,Molekylär och morfologisk patologi
show more...
Nilsson, Mats (author)
Uppsala universitet,Molekylära verktyg
Landegren, Ulf (author)
Uppsala universitet,Molekylära verktyg
Bergquist, Jonas (author)
Uppsala universitet,Analytisk kemi
Khan, Mohid S. (author)
Millar, Robert P. (author)
Långström, Bengt (author)
Uppsala universitet,Fysikalisk-organisk kemi
Borlak, Jurgen (author)
Eriksson, Barbro (author)
Uppsala universitet,Endokrin tumörbiologi
Nielsen, Bengt (author)
Baltzer, Lars (author)
Uppsala universitet,Fysikalisk-organisk kemi
Waterton, John C. (author)
Ahlström, Håkan (author)
Uppsala universitet,Enheten för radiologi
Öberg, Kjell (author)
Uppsala universitet,Onkologisk endokrinologi
show less...
 (creator_code:org_t)
2013-06-28
2013
English.
In: Neuroendocrinology. - : S. Karger AG. - 0028-3835 .- 1423-0194. ; 98:1, s. 16-30
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the diffuse neuroendocrine system or endocrine glands. Although traditionally understood to be a rare disease, the incidence and prevalence of NET have increased greatly in the past 3 decades. However, during this time, progress in diagnosis and outcome of NET has generally been modest. In order to achieve improved outcome in NET, a better understanding of NET biology combined with more reliable serum markers and better techniques to identify tumor localization and small lesions are needed. Although some NET biomarkers exist, sensitive and specific markers that predict tumor growth and behavior are generally lacking. In addition, the integration of new molecular imaging technologies in patient diagnosis and follow-up has the potential to enhance care. To discuss developments and issues required to improve diagnostics and management of NET patients, with specific focus on the latest advances in molecular imaging and biomarker science, 17 global leaders in the fields of NET, molecular imaging and biomarker technology gathered to participate in a 2-day meeting hosted by Prof. Kjell Oberg at the University of Uppsala in Sweden. During this time, findings were presented regarding methods with potential prognostic and treatment applications in NET or other types of cancers. This paper describes the symposium presentations and resulting discussions.

Keyword

Biomarkers
Circulating tumor cells
Molecular imaging
Neuroendocrine tumors

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view